Patents by Inventor Holger Bang

Holger Bang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Process for diagnosing rheumatic diseases
    Patent number: 8999921
    Abstract: The invention relates to polypeptides reacting with rheumatism-associated autoantibodies. The invention moreover relates to a diagnostic agent comprising any of said polypeptides, to a diagnostic kit comprising said diagnostic agent and to a process for in vitro detection of rheumatic diseases. The invention furthermore relates to a medicament comprising any of said polypeptides and to the use of said polypeptides for preparing a medicament for the prophylaxis and/or treatment of rheumatic diseases.
    Type: Grant
    Filed: June 27, 2006
    Date of Patent: April 7, 2015
    Assignee: Cypress Bioscience, Inc.
    Inventors: Holger Bang, Wigbert Berg
  • Process for diagnosing rheumatic diseases
    Publication number: 20090155822
    Abstract: The invention relates to polypeptides reacting with rheumatism-associated autoantibodies. The invention moreover relates to a diagnostic agent comprising any of said polypeptides, to a diagnostic kit comprising said diagnostic agent and to a process for in vitro detection of rheumatic diseases. The invention furthermore relates to a medicament comprising any of said polypeptides and to the use of said polypeptides for preparing a medicament for the prophylaxis and/or treatment of rheumatic diseases.
    Type: Application
    Filed: June 27, 2006
    Publication date: June 18, 2009
    Inventors: Holger Bang, Wigbert Berg
  • PROCESS FOR THE DIAGNOSTIC ASSESSMENT AND MONITORING, AS WELL AS MEDICAMENTS FOR THE THERAPY OF STATES OF SHOCK IN HUMANS
    Publication number: 20020039756
    Abstract: Patients suffering from shock illness exhibit increased levels of cyclophilins. Accordingly, methods for diagnosing, monitoring and treating shock patients are disclosed. Medicaments for therapeutically treating patients suffering from shock illness are also provided, for example, Cyclosporin A.
    Type: Application
    Filed: June 30, 1999
    Publication date: April 4, 2002
    Applicant: FOLEY AND LARDNER
    Inventors: HOLGER BANG, KAY BRUNE, ALBRECHT WENDEL, GESA TIEGS
  • Specific immunophilin ligands as antiasthmatics and immunosuppressants
    Patent number: 6258815
    Abstract: The novel specific immunophilin ligands of the general formula I have an antiasthmatic and immunosuppressive action and are suitable for the preparation of drugs.
    Type: Grant
    Filed: April 25, 1997
    Date of Patent: July 10, 2001
    Assignee: ASTA Medica Aktiengesellschaft
    Inventors: Dietmar Reichert, Bernhard Kutscher, Holger Bang, Kay Brune, Gerhard Quinkert, Hans-Günter Schaible
  • Immunophilin ligands
    Patent number: 6251932
    Abstract: The invention relates to an immunophilin ligand of Formula I and having antiasthmatic, antiallergic, antirheumatic, immunosuppressant, antipsoriatic and neuroprotectant properties,
    Type: Grant
    Filed: September 25, 1998
    Date of Patent: June 26, 2001
    Assignee: ASTA Medica AG
    Inventors: Dietmar Reichelt, Berhard Kutscher, István Szelényi, Hildegard Poppe, Gerhard Quinkert, Kay Brune, Holger Bang, Holger Deppe
  • Process for the diagnostic assessment and monitoring, as well as medicaments for the therapy of states of shock in humans
    Patent number: 6066465
    Abstract: A method is provided for detecting shock by measuring the concentration of cyclophilins in a patient's blood and comparing the measured concentration against a control. The severity of shock is then evaluated, an increase in cyclophilin concentrations over control levels being associated with severity. Measuring methods include enzymological techniques, such as rotomase activity assay; immunological procedures, such as radioimmunoassay and ELISA; peptide chemical processes, such as affinity chromatography; and radiochemical approaches, such as contacting the sample with radioactive cyclosporin.
    Type: Grant
    Filed: June 3, 1997
    Date of Patent: May 23, 2000
    Assignee: Paz Arzneimittel-Entwicklungsgesellschaft mbH
    Inventors: Holger Bang, Kay Brune, Albrecht Wendel, Gesa Tiegs